Achyut Healthcare Limited announced the successful completion of a preferential allotment of 58,00,000 equity shares worth ₹3,48,00,000, following Board approval on March 23, 2026. The Board meeting, held from 5:00 P.M. to 5:45 P.M. (IST), approved the allotment under SEBI regulations to promoter and non-promoter groups.

Board Meeting Outcomes and Regulatory Compliance

The Board of Directors approved the allotment of 58,00,000 equity shares of face value ₹1 each at a premium of ₹5 per share, setting the issue price at ₹6 per equity share. The company received the full consideration amount of ₹3,48,00,000 for this preferential issue conducted under SEBI (Issue of Capital & Disclosures Requirement) Regulation, 2018.

The allotment complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated November 11, 2024. The newly allotted equity shares will rank pari passu with existing equity shares in all respects, including dividend payments and voting rights.

Capital Structure Enhancement

Following the preferential allotment, the company's capital structure has been significantly enhanced:

Detailed Allottee Information

The preferential allotment was distributed among promoters, promoter group entities, and non-promoter investors with specific shareholding patterns:

Ray Remedies Private Limited Regulatory Disclosure

Ray Remedies Private Limited filed a regulatory disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, on March 24, 2026. The disclosure was submitted to BSE Limited and the Board of Directors of Achyut Healthcare Limited following the receipt of allotment through preferential basis.

The disclosure details show Ray Remedies Private Limited's shareholding increased from 77,17,500 shares (3.20%) to 79,17,500 shares (3.28%) after acquiring 2,00,000 additional shares through the preferential allotment:

The disclosure was signed by Mahendra C. Raycha, Director of Ray Remedies Private Limited (DIN: 00577647), confirming the acquisition through preferential allotment basis. The acquired equity shares carry face value of ₹1 each and rank pari-passu with existing equity shares.

Issue Structure and Compliance

The preferential issue was executed in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, read with the Companies Act, 2013 and rules made thereunder. All procedural requirements for the private placement basis allotment have been fulfilled, with comprehensive disclosure details provided as required under the regulatory framework.

The allotted equity shares carry face value of ₹1 each and rank pari-passu with existing equity shares. The company's Managing Director, Jigen Jagdishbhai Modi (DIN: 03355555), signed the regulatory filings confirming the completion of this capital-raising exercise, which strengthens the company's financial position through the infusion of ₹3.48 crores.

AKSHIT M. RAYCHA HUF has filed a formal disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, following the acquisition of additional equity shares in Achyut Healthcare Limited through open market purchase on March 12, 2026. The regulatory filing was submitted to the BSE Limited's Listing Compliance Department.

Acquisition Details

The transaction involved the purchase of 10,985 equity shares through open market operations, representing a marginal increase in the promoter group entity's shareholding. The acquisition increased AKSHIT M. RAYCHA HUF's total shareholding from 4,538,520 shares to 4,549,505 shares.

Regulatory Compliance Framework

The disclosure was made in accordance with SEBI regulations governing substantial acquisition of shares. AKSHIT M. RAYCHA HUF, identified as belonging to the promoter group of Achyut Healthcare Limited, submitted the required documentation to fulfill regulatory compliance obligations. The entity maintains no encumbrances, pledges, or liens on the acquired shares.

Company Capital Structure

Achyut Healthcare Limited's equity structure remains unchanged following this transaction. The company maintains its listing on the Bombay Stock Exchange Limited with a stable capital base.

Transaction Documentation

The formal disclosure letter was submitted by AKSHIT M. RAYCHA HUF from their registered address in Ahmedabad to the BSE's Listing Compliance Department. The filing included detailed annexures as per the prescribed format under SEBI regulations, covering all aspects of the share acquisition including pre and post-acquisition holdings, voting rights, and transaction specifics.

No warrants, convertible securities, or other instruments entitling voting rights were involved in this transaction. The acquisition represents a routine increase in promoter group shareholding through standard market operations, with all regulatory requirements being duly fulfilled.